121 related articles for article (PubMed ID: 38199050)
1. Antitumor active trans‑platinum complexes through metabolic stability and enhanced cellular accumulation.
Menon V; Katner SJ; Lee DE; Peterson EJ; Koblinski JE; Farrell NP
J Inorg Biochem; 2024 Mar; 252():112475. PubMed ID: 38199050
[TBL] [Abstract][Full Text] [Related]
2. Modulation of drug activation profiles through carboxylate ligand modification in cytotoxic trans-platinum planar amine compounds.
Benedetti BT; Quintal S; Farrell NP
Dalton Trans; 2011 Nov; 40(41):10983-8. PubMed ID: 21918760
[TBL] [Abstract][Full Text] [Related]
3. Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin.
Murphy RF; Komlodi-Pasztor E; Robey R; Balis FM; Farrell NP; Fojo T
Cell Cycle; 2012 Mar; 11(5):963-73. PubMed ID: 22333583
[TBL] [Abstract][Full Text] [Related]
4. Promotion of DNA strand breaks, interstrand cross-links and apoptotic cell death in A2780 human ovarian cancer cells by transplatinum planar amine complexes.
Aris SM; Gewirtz DA; Ryan JJ; Knott KM; Farrell NP
Biochem Pharmacol; 2007 Jun; 73(11):1749-57. PubMed ID: 17418817
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of aqueous solubility and stability employing a trans acetate axis in trans planar amine platinum compounds while maintaining the biological profile.
Ma ES; Bates WD; Edmunds A; Kelland LR; Fojo T; Farrell N
J Med Chem; 2005 Sep; 48(18):5651-4. PubMed ID: 16134932
[TBL] [Abstract][Full Text] [Related]
7. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.
Farrell N; Kelland LR; Roberts JD; Van Beusichem M
Cancer Res; 1992 Sep; 52(18):5065-72. PubMed ID: 1516063
[TBL] [Abstract][Full Text] [Related]
8. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR
Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands.
Coluccia M; Nassi A; Boccarelli A; Giordano D; Cardellicchio N; Locker D; Leng M; Sivo M; Intini FP; Natile G
J Inorg Biochem; 1999 Oct; 77(1-2):31-5. PubMed ID: 10626350
[TBL] [Abstract][Full Text] [Related]
10. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
[TBL] [Abstract][Full Text] [Related]
11. Effects of noncovalent platinum drug-protein interactions on drug efficacy: use of fluorescent conjugates as probes for drug metabolism.
Benedetti BT; Peterson EJ; Kabolizadeh P; Martínez A; Kipping R; Farrell NP
Mol Pharm; 2011 Jun; 8(3):940-8. PubMed ID: 21548575
[TBL] [Abstract][Full Text] [Related]
12. Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes.
Lin M; Wang X; Zhu J; Fan D; Zhang Y; Zhang J; Guo Z
Apoptosis; 2011 Mar; 16(3):288-300. PubMed ID: 21107699
[TBL] [Abstract][Full Text] [Related]
13. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.
Zhao Y; Woods JA; Farrer NJ; Robinson KS; Pracharova J; Kasparkova J; Novakova O; Li H; Salassa L; Pizarro AM; Clarkson GJ; Song L; Brabec V; Sadler PJ
Chemistry; 2013 Jul; 19(29):9578-91. PubMed ID: 23733242
[TBL] [Abstract][Full Text] [Related]
14. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
15. Relevance of the leaving group for antitumor activity of new platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Marqués-Gallego P; Contaldi S; den Dulk H; Monari M; Brouwer J; Jaehde U; Kalayda GV; Reedijk J
J Inorg Biochem; 2009 Dec; 103(12):1602-8. PubMed ID: 19783310
[TBL] [Abstract][Full Text] [Related]
16. A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
Shahsavar F; Bozorgmehr M; Mirzadegan E; Abedi A; Lighvan ZM; Mohammadi F; Safari N; Amani V; Zarnani AH
Anticancer Agents Med Chem; 2016; 16(3):393-403. PubMed ID: 26899296
[TBL] [Abstract][Full Text] [Related]
17. Novel bis-platinum complexes endowed with an improved pharmacological profile.
Gatti L; Perego P; Leone R; Apostoli P; Carenini N; Corna E; Allievi C; Bastrup U; De Munari S; Di Giovine S; Nicoli P; Grugni M; Natangelo M; Pardi G; Pezzoni G; Singer JW; Zunino F
Mol Pharm; 2010 Feb; 7(1):207-16. PubMed ID: 19919086
[TBL] [Abstract][Full Text] [Related]
18. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
Yoshida M; Khokhar AR; Siddik ZH
Cancer Res; 1994 Jul; 54(13):3468-73. PubMed ID: 8012968
[TBL] [Abstract][Full Text] [Related]
19. Studies on the Complexation of Platinum(II) by Some 4-Nitroisoxazoles and Testing the Cytotoxic Activity of the Resulting Complexes.
Mastalarz H; Mastalarz A; Wietrzyk J; Milczarek M; Kochel A; Regiec A
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770951
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of antitumor platinum(II) agents conjugated with non-steroidal anti-inflammatory drug species.
Zang J; Zhang B; Wang Y; Wang X; Gou S
Bioorg Chem; 2022 Mar; 120():105633. PubMed ID: 35091288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]